logo
  • Resources by Tumor Type
  • Provider Resources
    • Care Step Pathways
    • Continuing Education
    • Provider Toolkits
    • Healthcare Disparities
      • Primer
      • Videos
    • ctDNA Testing for Response Monitoring
    • News
  • Patient/Caregiver Resources
    • Patient Action Plans
    • Caregiver Resource
    • Options for Stage IV Melanoma
    • Options for Stage III Melanoma
    • Options for Stage II Melanoma
    • Non-Invasive Evaluation Tools (Melanoma)
    • ctDNA Testing Handout
  • International Resources
    • Australia
    • Canada
    • France
    • Germany
    • Italy
    • Portugal
    • Spain
    • UK
  • Videos
    • HCP Videos
    • Patient Videos
  • Resources by Tumor Type
  • Provider Resources
    • Care Step Pathways
    • Continuing Education
    • Provider Toolkits
    • Healthcare Disparities
      • Primer
      • Videos
    • ctDNA Testing for Response Monitoring
    • News
  • Patient/Caregiver Resources
    • Patient Action Plans
    • Caregiver Resource
    • Options for Stage IV Melanoma
    • Options for Stage III Melanoma
    • Options for Stage II Melanoma
    • Non-Invasive Evaluation Tools (Melanoma)
    • ctDNA Testing Handout
  • International Resources
    • Australia
    • Canada
    • France
    • Germany
    • Italy
    • Portugal
    • Spain
    • UK
  • Videos
    • HCP Videos
    • Patient Videos

ImmunoHub.org – Immuno-Oncology Essentials – Home › Forums › Intralesional immunotherapy

  • This category has 5 topics, 16 replies, and was last updated February 11, 2018 at 12:00 am by Krista Rubin.
    • Forum
    • Topics
    • Posts
    • Last Post
    • Expectations for therapy
    • 0
    • 0
    • No Topics

    • Dosing and administration
    • 1
    • 3
    • Reply To: Pharmacy and nurse roles

      December 24, 2017 at 4:06 pm

      Kathleen Madden

    • Infectious Precautions
    • 2
    • 9
    • Reply To: TVEC infection control practices

      February 11, 2018 at 12:00 am

      Krista Rubin

    • Side-effect management
    • 1
    • 8
    • Reply To: Ocular herpes

      January 5, 2018 at 2:54 am

      Virginia Seery

    • Reimbursement
    • 1
    • 1
    • December 8, 2017 at 4:58 pm

    • Other
    • 0
    • 0
    • No Topics

  •  

Login

Log In
Register Lost Password

Latest Activity

  • New BRAF/MEK inhibitors coming to market
    topic by Lisa Kottschade
    March 1
    in Dosing and administration
  • Adjuvant Immunotherapy in stage IIIA patients
    topic by Lisa Kottschade
    March 1
    in Expectations for therapy
  • Influenza and Tamiflu and Immunotherapy
    reply by Kathleen Madden
    February 25
    in Other
  • ASCO/NCCN guidlines now out
    reply by Mollie Reed
    February 23
    in Side-effect management
  • hepatotoxicity
    reply by Mollie Reed
    February 23
    in Side-effect management
© 2023 ImmunoHub.org. All rights reserved.
  • About
  • Terms
  • Privacy
  • Contact